(HCMT) - Ratings and Ratios
U.S. Equity Securities, Cash Equivalents, Large-Cap Stocks
Description: HCMT
The Direxion Shares ETF Trust (HCMT) is an actively managed exchange-traded fund that aims to deliver amplified returns across various market cycles, closely tied to the performance of the U.S. equity markets. By dynamically allocating its assets, the fund seeks to capitalize on upward trends in the market while mitigating potential losses during downturns by investing in cash or cash equivalents.
The funds investment strategy is centered around achieving capital appreciation through exposure to U.S. equity securities, indicating a proactive approach to navigating market fluctuations. As a non-diversified fund, HCMT is not constrained by the need to spread its investments across a broad spectrum of assets, allowing it to focus on specific opportunities that align with its objectives.
Analyzing the available data, we observe that HCMT has experienced significant price movements over the past year, with a 52-week high of $39.14 and a low of $24.95. The current price of $27.11 is below its 50-day and 200-day simple moving averages (SMA50 and SMA200), indicating a potential bearish trend. However, the short-term SMA20 is at $26.40, suggesting a possible recovery trajectory if the price continues to stay above this level.
Given the current technical indicators and fundamental data, a forecast for HCMT could involve a potential short-term rebound if it can sustain its price above the SMA20. However, the long-term trend remains bearish as long as the price stays below the SMA50 and SMA200. With an AUM of $359.84M, the fund has sufficient assets to maintain its investment strategies. If the U.S. equity markets experience a significant upswing, HCMT is poised to benefit due to its exposure to U.S. equity securities, potentially leading to capital appreciation. Conversely, during market downturns, its ability to invest in cash or cash equivalents could help preserve capital.
To capitalize on potential opportunities, investors should closely monitor the funds price movements relative to its moving averages and adjust their strategies accordingly. A break above the SMA50 could signal a shift towards a more bullish trend, while a failure to recover could lead to further declines.
Additional Sources for HCMT ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
HCMT ETF Overview
Market Cap in USD | 452m |
Category | Large Blend |
TER | 1.17% |
IPO / Inception | 2023-06-21 |
HCMT ETF Ratings
Growth Rating | 26.0 |
Fundamental | - |
Dividend Rating | 43.2 |
Rel. Strength | -15.7 |
Analysts | - |
Fair Price Momentum | 30.44 USD |
Fair Price DCF | - |
HCMT Dividends
Dividend Yield 12m | 2.83% |
Yield on Cost 5y | 3.86% |
Annual Growth 5y | 142.52% |
Payout Consistency | 66.7% |
Payout Ratio | % |
HCMT Growth Ratios
Growth Correlation 3m | 93.9% |
Growth Correlation 12m | -33.4% |
Growth Correlation 5y | 68.9% |
CAGR 5y | 16.10% |
CAGR/Max DD 5y | 0.44 |
Sharpe Ratio 12m | 1.48 |
Alpha | -27.51 |
Beta | 1.899 |
Volatility | 24.42% |
Current Volume | 57.1k |
Average Volume 20d | 61.2k |
As of July 04, 2025, the stock is trading at USD 33.12 with a total of 57,084 shares traded.
Over the past week, the price has changed by +3.86%, over one month by +10.44%, over three months by +17.36% and over the past year by -3.16%.
Neither. Based on ValueRay´s Analyses, is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 26.01 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of HCMT is around 30.44 USD . This means that HCMT is currently overvalued and has a potential downside of -8.09%.
has no consensus analysts rating.
According to our own proprietary Forecast Model, HCMT will be worth about 36.5 in July 2026. The stock is currently trading at 33.12. This means that the stock has a potential upside of +10.3%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 36.5 | 10.3% |